Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo (Q73755539)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10799756%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10799756%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

H Q Wu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10799756%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P Guidetti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10799756%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J H Goodman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10799756%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Varasi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10799756%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

G Ceresoli-Borroni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10799756%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

C Speciale

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10799756%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

H E Scharfman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10799756%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

R Schwarcz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10799756%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10799756%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10799756%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10799756%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10799756%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

243-251

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10799756%20AND%20SRC:MED&resulttype=core&format=json

Long-term and short-term plasticity in the CA1, CA3, and dentate regions of the rat hippocampal slice.

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Quinolinic acid in vivo synthesis rates, extracellular concentrations, and intercompartmental distributions in normal and immune-activated brain as determined by multiple-isotope microdialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Organic ion transport during seven decades. The amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

The role of hydrogen peroxide in the in vitro cytotoxicity of 3-hydroxykynurenine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Neurotoxin quinolinic acid is selectively elevated in spinal cords of rats with experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Blood?Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

The neuroprotective actions of kynurenic acid and MK-801 in gerbils are synergistic and not related to hypothermia.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Metabolism of [5-3H]kynurenine in the rat brain in vivo: evidence for the existence of a functional kynurenine pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Quantification of 3-hydroxykynurenine in brain by high-performance liquid chromatography and electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Regional brain and cerebrospinal fluid quinolinic acid concentrations in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Interference with cellular energy metabolism reduces kynurenic acid formation in rat brain slices: reversal by lactate and pyruvate.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Intravenous administration of L-kynurenine to rhesus monkeys: effect on quinolinate and kynurenate levels in serum and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Glycine potentiates the NMDA response in cultured mouse brain neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Brain tryptophan metabolism in schizophrenia: A post mortem study of metabolites on the serotonin and kynurenine pathways in schizophrenic and control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Modulation of Quinolinic and Kynurenic Acid Content in the Rat Brain: Effects of Endotoxins and Nicotinylalanine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Presence of Kynurenic Acid in the Mammalian Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Determination of 3-hydroxykynurenine in human brain and plasma by high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Quinolinic acid in neurological disease: opportunities for novel drug discovery.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Increased brain 3-hydroxykynurenine in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Systemic DL-kynurenine and probenecid pretreatment attenuates quinolinic acid-induced neurotoxicity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Effects of central and peripheral administration of kynurenic acid on hippocampal evoked responses in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Differential vulnerability of central neurons of the rat to quinolinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Kynurenic acid-enhancing and anti-ischemic effects of the potent kynurenine 3-hydroxylase inhibitor FCE 28833 in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

High-affinity uptake of L-kynurenine by a Na+-independent transporter of neutral amino acids in astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

(R,S)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Determination of extracellular kynurenic acid in the striatum of unanesthetized rats: effect of aminooxyacetic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Identification and quantification of kynurenic acid in human brain tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

High-performance liquid chromatographic assay of human lymphocyte kynureninase activity levels

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2800%2900030-0

7 January 2021

10.1016/S0306-4522(00)00030-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10799756%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference